ProShare Advisors LLC Has $2.76 Million Holdings in Teleflex Incorporated (NYSE:TFX)

ProShare Advisors LLC boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 34.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 12,200 shares of the medical technology company’s stock after acquiring an additional 3,105 shares during the quarter. ProShare Advisors LLC’s holdings in Teleflex were worth $2,759,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. lifted its stake in Teleflex by 15.8% during the first quarter. Russell Investments Group Ltd. now owns 18,838 shares of the medical technology company’s stock worth $4,245,000 after purchasing an additional 2,570 shares during the last quarter. Sei Investments Co. lifted its stake in Teleflex by 22.0% during the first quarter. Sei Investments Co. now owns 23,012 shares of the medical technology company’s stock worth $5,205,000 after purchasing an additional 4,156 shares during the last quarter. Forsta AP Fonden lifted its stake in Teleflex by 15.7% during the first quarter. Forsta AP Fonden now owns 10,300 shares of the medical technology company’s stock worth $2,330,000 after purchasing an additional 1,400 shares during the last quarter. SG Americas Securities LLC lifted its stake in Teleflex by 415.3% during the first quarter. SG Americas Securities LLC now owns 6,920 shares of the medical technology company’s stock worth $1,565,000 after purchasing an additional 5,577 shares during the last quarter. Finally, Quantbot Technologies LP bought a new stake in Teleflex during the first quarter worth $537,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on TFX shares. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $205.00 to $245.00 in a report on Monday, July 1st. Finally, Truist Financial increased their price objective on Teleflex from $235.00 to $240.00 and gave the company a “hold” rating in a report on Tuesday. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $263.14.

Teleflex Stock Performance

Shares of Teleflex stock opened at $220.19 on Friday. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average price of $211.32 and a two-hundred day moving average price of $223.12. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $262.97. The company has a market cap of $10.37 billion, a P/E ratio of 35.34, a PEG ratio of 2.23 and a beta of 1.13.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, topping analysts’ consensus estimates of $3.07 by $0.14. The firm had revenue of $737.80 million during the quarter, compared to the consensus estimate of $726.85 million. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The business’s revenue was up 3.8% compared to the same quarter last year. During the same period last year, the business posted $3.09 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.75 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Wednesday, May 15th were given a $0.34 dividend. The ex-dividend date was Tuesday, May 14th. This represents a $1.36 annualized dividend and a yield of 0.62%. Teleflex’s payout ratio is 21.83%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.